key: cord-0692304-7t3nfjrx
authors: Kowalska, J. D.; Skrzat-Klapaczyńska, A.; Bursa, D.; Balayan, T.; Begovac, J.; Chkhartishvili, N.; Gokengin, D.; Harxhi, A.; Jilich, D.; Jevtovic, D.; Kase, K.; Lakatos, B.; Matulionyte, R.; Mulabdic, V.; Nagit, A.; Papadopoulos, A.; Stefanovic, M.; Vassilenko, A.; Vasylyev, M.; Yancheva, N.; Yurin, O.; Horban, A.
title: HIV care in times of the COVID-19 crisis – where are we now in Central and Eastern Europe?
date: 2020-05-11
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.05.013
sha: 128cfbc19443d678274bc80f00cd82ba51ab36d1
doc_id: 692304
cord_uid: 7t3nfjrx

Abstract Introduction The SARS-CoV-2 pandemic hit disproportionately European region. Many HIV clinics share staff and logistics with infectious disease facilities, which are now on the frontline of COVID-19. Therefore, we investigated the impact of current pandemic situation on HIV care and continuity of antiretroviral treatment (ART) supplies in CEE countries. Methods Euroguidelines in Central and Eastern Europe (ECEE) Network Group was established in February 2016 to review standards of care for HIV in the region. The group consists of professionals actively involved in HIV care. On 19th March we decided to review the status of HIV care sustainability in the face of emerging SARS-CoV-2 pandemic in Europe. For this purpose, we constructed an on-line survey consisting of 23 questions. Respondents were recruited from the ECEE members in 22 countries, based on their involvement in HIV care and contacted through e-mails. Results In total 19 countries responded: Albania, Armenia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Greece, Hungary, Lithuania, Macedonia, Poland, Republic of Moldova, Russia, Serbia, Turkey, Ukraine. Most of the respondents were infectious disease physicians directly involved in HIV care (17/19). No country reported HIV clinic closure. HIV clinics were operating normally in only six countries (31.6%). In 11 (57.9%) countries physicians were sharing HIV care and COVID-19 care duties. None of the countries expect shortage of ART in the next two weeks; however five physicians expressed uncertainty about the next two months. At the time of providing responses ten (52.6%) countries had HIV-positive persons under quarantine. Conclusions The shortage of resources is evident and the impact on HIV care inevitable. We need to prepare for operating under minimal medical resources with the aim to secure retention on ART. Non-governmental organizations should re-validate their earlier objectives and second medical efforts to ascertain the continuity of ART deliverance.

The SARS-CoV-2 pandemic hit disproportionately European region. Many HIV clinics share staff and logistics with infectious disease facilities, which are now on the frontline of COVID-19. Therefore, we investigated the impact of current pandemic situation on HIV care and continuity of antiretroviral treatment (ART) supplies in CEE countries. The SARS-CoV-2 pandemic hit disproportionately European region, with over half of a million people being infected with the virus within four weeks, of whom more than 40 000 died [1] . So far this represents half of all confirmed cases worldwide and two thirds of deaths. There is increasing worry that low and middle income countries are not testing for SARS-CoV-2, therefore the number remains strongly underreported for some Central and Eastern European (CEE) countries. This is the middle ground where uncontrolled coronavirus pandemic meets fragile or basic healthcare systems.

Many HIV clinics share staff and logistics with infectious disease facilities, which are now on the frontline of COVID-19. Therefore, we investigated the impact of current SARS-CoV-2 pandemic situation on HIV care and continuity of antiretroviral treatment (ART) supplies in CEE countries.

Euroguidelines in Central and Eastern Europe (ECEE) Network Group was established in February 2016 to review standards of care for HIV in the region. The group consists of experts in the HIV field being at the same time professionals actively involved in HIV patients' care. In addition to yearly meetings being held in Warsaw, the group acts through on-line surveys using repeatedly the same method [2] . On 19 th March we decided to review the status of HIV care sustainability in the face of emerging COVID-19 pandemic in Europe. For this purpose, we constructed an on-line survey consisting of 23 questions, Most were open-ended with a predefined multiple choice answers plus an 'other' option providing space for the respondent's free-text reply (Appendix). Respondents were recruited from the ECEE members in 22 countries (one per country), based on their involvement in HIV care, and contacted through e-mails. No country reported HIV clinic closure. HIV clinics were operating normally in six countries (31.6%). In three countries there were either shorter hours or reduced staff and in ten (52.6%) normal activity (regular visits and blood tests) was suspended and only ART distribution was continued. In 11 (57.9%) countries physicians were sharing HIV care and COVID-19 care duties (Figure) .

In most countries ART was dispensed for 2-3 months (13/19), in five for 4-6 months and in one for a month. None of the countries expect shortage of ART in the next two weeks; however five physicians expressed uncertainty about the next two months. In eight countries respondents reported that procurement might be endangered in respondent's opinion. One person expressed concern related to possible lopinavir/ritonavir stock-outs related to its wider use for COVID-19 patients. Three persons expressed uncertainty related to economic situation after the pandemic, which could affect governments' ability to continue ART procurement.

In eight countries respondents indicated that HIV clinics were contacted by HIV-positive person(s) who were not under their care, but unable to return to their place of residence due to SARS-CoV-2 pandemic related restrictions. In all cases HIV-positive persons were provided with ART free of charge.

J o u r n a l P r e -p r o o f 7 At the time of providing responses ten (52.6%) countries had HIV-positive persons under SARS-CoV-2 related quarantine.

In our survey almost 60% of responding countries reported that HIV physicians were at the same time directly involved in work related to COVID-19 patients. Infectious diseases physicians, who take care of HIV-positive patients, are likely to be fully occupied with the current SARS-CoV-2 situation.

This area of medical specialty has been for many years underfinanced and underpowered in CEE countries and is not easily replaceable. In addition, medical staff will most likely face exhaustion, trauma and negative psychological effects [3] .

In our study only around 30% of the countries continued to have HIV clinics working normally.

Healthcare systems in Europe were hit hard by the high number of COVID-19 cases and the severity of the disease [4] . As a result both acute and chronic medical conditions unrelated to COVID-19 are down prioritized, which is especially difficult when patients are dependent on their clinics in terms of continuity of drug supply. COVID-19 pandemic poses a threat to HIV continuum of care at any given stage [5] . Half of the countries in CEE reported SARS-CoV-2 quarantines applying also to HIVpositive persons and in eight countries ART was provided for people who were restricted to travel back to their place of residency. A survey performed in February 2020 during SARS-CoV-2 outbreak in China showed that one in three HIV-positive persons were not carrying enough ART to cover for special travelling restrictions and two out of three in Hubei province reported difficulty in obtaining ART [6] .

. In addition remaining in isolation and social distancing measures may fuel negative psychological effects. In CEE region many HIV-positive people come from vulnerable populations and already experience stigmatization and loneliness [7] . Taking lessons from previous epidemics we should acknowledge that in people exposed to a stressful event during pandemic depression is highly likely to occur [8] . All this factors may affect adherence and retention in care. At the same time patients J o u r n a l P r e -p r o o f 8 with advanced or uncontrollable HIV infection may be more vulnerable to COVID-19 disease, and half of them has co-morbidities increasing COVID-19 severity [9] .

In most CEE countries HIV care is organized in the way that ART is bought centrally and distributed throughout designated clinics [10] . Moreover, ART procurement varies by country and relays on complicated administrative procedures, many ART components are not produced locally. According to our data most countries dispensed ART for 2-3 months and some respondents expressed uncertainty about the sustainability of supplies. Almost half of our respondents indicated that procurement processes might be further impacted due to the current pandemic. It seems inevitable that international organizations collaborate with governments in CEE countries in order to provide additional financial and logistic support in this area [11] .

There are some important limitations in relation to this work that needs to be mentioned. As this is a survey study, represented by a single person on behalf of a country, the answers could be subjective and express opinion of a respondent. However each country is represented by a nationally recognized expert in the field being also actively involved in HIV patients' care [2] . Therefore we believe that responses are accurately reflecting the situation in a given country and thus provide a reliable sample. The group has been reviewing many aspects of standards of HIV care in the past using the same method [12] . Finally, survey studies are conducted in order to gather large size of information in a short period of time, however they carry certain bias and should be interpreted with caution. As the SARS-CoV-2 pandemic continues we need to prepare for operating under minimal medical resources with the aim to secure retention on ART. Non-governmental organizations (NGOs) should re-validate their earlier objectives and second medical efforts to ascertain the continuity of 

Antonyak S (Ukraine), Balayan T (Armenia), Bednarska A (Poland)

Jevtovic D (Serbia)

Mardarescu M (Romania), Matłosz B (Poland), Matulyte E (Lithuania)

Mulabdic V (Bosnia-Herzegovina)

Panteleyev A (Russia), Papadopoulos A (Greece)

Rukhadze (Georgia)

Skrzat-Klapaczynska A (Poland), Sluzhynska M

European Centre for Disease Prevention and Control. Epidemiological Update. Situation update worldwide, as of 4th

Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration -a comprehensive meeting report

The mental health of medical workers in

China dealing with the 2019 novel coronavirus

COVID-19 in Europe: the Italian lesson

Maintaining HIV care during the COVID-19 pandemic

People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe -data from Euro-guidelines in Central and Eastern Europe Network

Depression after exposure to stressful events: lessons learned from the severe acute respiratory syndrome epidemic

Statement on risk of COVID-19 for people living with HIV (PLWH)

HIV care in Central and Eastern Europe: How close are we to the target?

UNAIDS and China working together during the COVID-19 outbreak to ensure that people living with HIV continue to get treatment

Date accessed

HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

The authors declare no conflict of interest and this project did not receive any funding. According to local low there is no requirement to obtain bioethical committee approval.